Graphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…
5 years ago
Wire Stories
Graphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…
5 years ago
Boston Metal Wins S&P Global Platts Global Metals Award
Winners announced in London, UK BOSTON--(BUSINESS WIRE)--Boston Metal won the New Technology for the Metals…
5 years ago
Graphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…
5 years ago
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…
5 years ago
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…
5 years ago
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…
5 years ago
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…
5 years ago
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…
5 years ago
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…
5 years ago